Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Nodular Lymphocyte Predominant B-Cell Lymphoma — Genomics · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Lymphoma
Nodular Lymphocyte Predominant B-Cell Lymphoma

Hematologic Malignancy

Nodular Lymphocyte Predominant B-Cell Lymphoma

CI-CAN-00001280NLPBL · NLPHLExplore in graph →

Hematologic2 active trials

NCIt: C7258
OncoTree: NLPHL
UMLS CUI: C1334968

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials16
Research
Rankings
Sources & provenance

Genomics

Gene alteration frequencies by cohort

Data not yet available

No genomic cohort is mapped to this entity or its descendants. Frequencies come from open-access cohorts (GDC projects) and always carry their denominator (cases profiled); they are never pooled across cohorts.

What CancerIndex knows

Variants & evidence
Genes index